Pfizer is one of the world’s premier innovative biopharmaceutical businesses: discovering, developing and delivering over 100 assorted medicines, vaccines and consumer healthcare products round the world. The company first commenced operations in Italy back in the 1950s, contributing significantly to the host nation’s economic and workforce development and investing heavily in innovation and R&D. Today Pfizer ranks as the largest pharmaceutical enterprise in the country.
Contact:
Address:
Sede Legale: Via Isonzo, 71 – 04100 Latina
Sede Commerciale: Via Valbondione 113, 00188 Roma
Tel: +39 06 331821
Fax: +39 06 33626019
Paivi Kerkola, Country Manager, Managing Director and President of Pfizer Italy, speaks about the peculiarities of the Italian market from a northern European perspective, her priorities, and the impact of…
Massimo Visentin, Country Leader for Pfizer Italy, discusses the company’s remarkable success in 2015, his hopes and ambitions for the new year, and the need of the industry and Pfizer…
Having led a 26 years long career in Pfizer, you have been involved in a number of different countries including leading markets such as the US and Japan, but also…
Having led a successful turnaround of the affiliate in just eight months, Nadia Cortesi of ResMed explains how she has achieved double digit growth, while facing sustained external challenges, including…
Despite the already existing efficiencies in the Italian healthcare system, there is still significant room for improvement. Johnson & Johnson Medical’s head for southern Europe discusses a number of opportunities…
3PL player BOMI Group went public via an IPO in June 2015. VP & CFO Marco Ruini discusses the reasons behind this Italian family company’s decision to go public, as well…
KPMG is committed to providing long-term support to public as well as private institutions as they tackle challenges and transform the way healthcare is provided. Alberto De Negri, partner of…
Angelini CEO Gianluigi Frozzi speaks about the company’s diverse portfolio of products, the “Made in Italy” brand, and the company’s continual global growth anchored strongly in innovation. Can you please give our…
As an emerging leader in mobile health and provider of innovative health-technologies, Philips is poised to provide Italian healthcare institutions with solutions that could enable significant gains in efficiency. CEO…
Biopharmaceutical logistics leader World Courier strives to understand their clients’ needs as early as possible, and the Italian affiliate has gone to unusual lengths, including joining the Italian biotech association,…
While the Italian clinical research community works to an excellent standard of quality, and is relatively competitive in terms of costs, regulatory differences with the rest of Europe pose significant…
Gnosis is a fully vertically integrated biotech company specialized in the manufacturing and sales of fermentation raw materials and natural finished products used in the pharmaceutical, nutraceutical, cosmetic, veterinary, and…
Charles-Henri Bodin, General Manager of Pierre Fabre, explains how the recent agreement with Pfizer on Toviaz will enlarge their footprint in Italy and how partnerships will play an increasing role…
Raffaele Stefanelli discusses the challenges of the medtech industry in Italy, the contribution of the Italian research community to Boston Scientific globally, and innovative partnership models. Could you introduce yourself…
Samsung is focused on the total digital transformation of medical services. It offers solutions in mobile health, hospital digitalization, and integrated medical and healthcare devices. The head of the healthcare…
See our Cookie Privacy Policy Here
